Dopamine D3 receptor blockade accelerates the extinction of opioid withdrawal-induced drug-seeking behaviours and alters microglia in dopaminoceptive nuclei.

IF 6.8 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Aurelio Franco-García, Victoria Gómez-Murcia, M Victoria Milanés, Cristina Núñez
{"title":"Dopamine D<sub>3</sub> receptor blockade accelerates the extinction of opioid withdrawal-induced drug-seeking behaviours and alters microglia in dopaminoceptive nuclei.","authors":"Aurelio Franco-García, Victoria Gómez-Murcia, M Victoria Milanés, Cristina Núñez","doi":"10.1111/bph.70081","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Among all drugs of abuse, opioids cause most of the deaths and treatment seeking. Despite abundant research in multifaceted therapeutic strategies, a high rate of relapse still characterises this condition. Dopamine D<sub>3</sub> receptor antagonists combined with cue-exposure therapies have been proposed to ameliorate the abused drugs-induced cognitive deficits, which consequently would aid to prevent the maladaptive behaviours responsible for drug use.</p><p><strong>Experimental approach: </strong>We used the morphine withdrawal-induced conditioned place aversion (CPA) paradigm to assess, in male rats, the efficacy of D<sub>3</sub> receptor blockade to improve the extinction of drug-seeking behaviours associated with the aversive contextual stimuli of its withdrawal. Then, using immunohistochemical methods, we evaluated the participation of neuroimmune mechanisms in the striatum and infralimbic cortex in D<sub>3</sub> receptor modulation of CPA extinction.</p><p><strong>Key results: </strong>Whereas the selective D<sub>3</sub> antagonist PG01037 accelerated the extinction of the morphine withdrawal-induced CPA, our findings indicate that decreased motivation might be involved in this action. Increased D<sub>3</sub> receptor expression in glial cells and the modulation of microglia activation state in specific dopaminoceptive areas could intervene in the behavioural outcomes of D<sub>3</sub> receptor blockade.</p><p><strong>Conclusions and implications: </strong>Our findings reveal a facilitatory role of D<sub>3</sub> antagonists in the inhibition of morphine-seeking behaviours triggered by contextual stimuli associated with its withdrawal. Nonetheless, their potential ability to reduce motivation might influence their therapeutic use. Future investigations elucidating the precise function of D<sub>3</sub> receptors will facilitate the identification of this receptor as a valuable therapeutic target for mitigating the recurrence of opioid withdrawal-induced drug-seeking behaviour.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bph.70081","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Among all drugs of abuse, opioids cause most of the deaths and treatment seeking. Despite abundant research in multifaceted therapeutic strategies, a high rate of relapse still characterises this condition. Dopamine D3 receptor antagonists combined with cue-exposure therapies have been proposed to ameliorate the abused drugs-induced cognitive deficits, which consequently would aid to prevent the maladaptive behaviours responsible for drug use.

Experimental approach: We used the morphine withdrawal-induced conditioned place aversion (CPA) paradigm to assess, in male rats, the efficacy of D3 receptor blockade to improve the extinction of drug-seeking behaviours associated with the aversive contextual stimuli of its withdrawal. Then, using immunohistochemical methods, we evaluated the participation of neuroimmune mechanisms in the striatum and infralimbic cortex in D3 receptor modulation of CPA extinction.

Key results: Whereas the selective D3 antagonist PG01037 accelerated the extinction of the morphine withdrawal-induced CPA, our findings indicate that decreased motivation might be involved in this action. Increased D3 receptor expression in glial cells and the modulation of microglia activation state in specific dopaminoceptive areas could intervene in the behavioural outcomes of D3 receptor blockade.

Conclusions and implications: Our findings reveal a facilitatory role of D3 antagonists in the inhibition of morphine-seeking behaviours triggered by contextual stimuli associated with its withdrawal. Nonetheless, their potential ability to reduce motivation might influence their therapeutic use. Future investigations elucidating the precise function of D3 receptors will facilitate the identification of this receptor as a valuable therapeutic target for mitigating the recurrence of opioid withdrawal-induced drug-seeking behaviour.

多巴胺D3受体阻断加速阿片戒断诱导的药物寻找行为的消失,并改变多巴胺感觉核中的小胶质细胞。
背景和目的:在所有滥用药物中,阿片类药物导致的死亡和寻求治疗最多。尽管对多方面的治疗策略进行了大量的研究,但复发率高仍然是这种疾病的特征。多巴胺D3受体拮抗剂联合线索暴露疗法已被提出用于改善滥用药物引起的认知缺陷,从而有助于预防导致药物使用的适应不良行为。实验方法:我们使用吗啡戒断诱导的条件场所厌恶(CPA)范式来评估雄性大鼠D3受体阻断对与戒断相关的厌恶情境刺激相关的药物寻求行为的消退的效果。然后,利用免疫组织化学方法,我们评估了纹状体和边缘下皮层的神经免疫机制在D3受体调节CPA消退中的作用。尽管选择性D3拮抗剂PG01037加速了吗啡戒断诱导的CPA的消失,但我们的研究结果表明,动机的降低可能参与了这一作用。胶质细胞中D3受体表达的增加和特定多巴胺感觉区小胶质细胞激活状态的调节可能干预D3受体阻断的行为结果。结论和意义:我们的研究结果揭示了D3拮抗剂在抑制与吗啡戒断相关的情境刺激引发的吗啡寻求行为中的促进作用。尽管如此,它们降低动机的潜在能力可能会影响它们的治疗用途。未来研究阐明D3受体的确切功能将有助于识别该受体作为减轻阿片类药物戒断诱导的药物寻求行为复发的有价值的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信